Ines Adriaenssen

机构：Johnson & Johnson (United States), Janssen (Belgium)

发表论文 31 篇 · 总被引 339 次 · h-index 9

代表论文

• Reliability, validity and ability to detect change of the clinician-rated Personal and Social Performance scale in patients with acute symptoms of schizophrenia (2009 · Current Medical Research and Opinion · 被引 127)
• Estimating survival gain for economic evaluations with survival time as principal endpoint: A cost‐effectiveness analysis of adding early hormonal therapy to radiotherapy in patients with locally advanced prostate cancer (2002 · Health Economics · 被引 35)
• Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: Interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets (2010 · Clinical Therapeutics · 被引 32)
• A pooled analysis of adjunctive topiramate in refractory partial epilepsy (2003 · Acta Neurologica Scandinavica · 被引 28)
• Cost Effectiveness of Paclitaxel/Cisplatin Compared with Cyclophosphamide/Cisplatin in the Treatment of Advanced Ovarian Cancer in Belgium (2002 · PharmacoEconomics · 被引 28)
• The costs of managing patients with advanced colorectal cancer in 10 different European centres (1999 · European Journal of Cancer · 被引 21)